Genome Medicine
-
Publication Venue For
- Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential.. 12:6. 2020
- A putative causal relationship between genetically determined female body shape and posttraumatic stress disorder.. 9:99. 2017
- Breathing new life into an old target: pulmonary disease drugs for Parkinson's disease therapy.. 9:88. 2017
- Creating a data resource: what will it take to build a medical information commons?. 9:84. 2017
- New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali.. 9:30. 2017
- Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits.. 9:29. 2017
- Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas.. 9:14. 2017
- Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance.. 7:98. 2015
- How behavioral economics can help to avoid 'The last mile problem' in whole genome sequencing.. 7:3. 2015
- Mutation signatures implicate aristolochic acid in bladder cancer development 2015
- Mutation signatures implicate aristolochic acid in bladder cancer development.. 7:38. 2015
- Patient engagement as a risk factor in personalized health care: A systematic review of the literature on chronic disease. 6. 2014
- An integrated transcriptome and expressed variant analysis of sepsis survival and death.. 6:111. 2014
- Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding.. 6:58. 2014
- Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention.. 6:24. 2014
- Patient engagement as a risk factor in personalized health care: a systematic review of the literature on chronic disease.. 6:16. 2014
- Variants of uncertain significance in BRCA: A harbinger of ethical and policy issues to come?. 6. 2014
- Constructing narratives of heroism and villainy: Case study of Myriad's BRACAnalysis® compared to Genentech's Herceptin®. 5. 2013
- Harm, hype and evidence: ELSI research and policy guidance.. 5:21. 2013
- Incremental value of rare genetic variants for the prediction of multifactorial diseases.. 5:76. 2013
- The emergence of commercial genomics: Analysis of the rise of a biotechnology subsector during the Human Genome Project, 1990 to 2004. 5. 2013
- H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island-containing start sites.. 4:47. 2012
- Gene patents and personalized medicine - what lies ahead?. 1:92. 2009
- From association to causality: the new frontier for complex traits.. 1:23. 2009
- Direct-to-consumer genetic tests: Beyond medical regulation?. 1. 2009